Health Care & Life Sciences » Biotechnology | ACADIA Pharmaceuticals Inc.

ACADIA Pharmaceuticals Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
185,790.00
322,486.00
215,132.00
529,036.00
341,342.00
473,520
Total Accounts Receivable
-
964.00
1,638.00
7,140.00
18,430.00
27,789
Inventories
-
-
-
4,175.00
5,248.00
4,070
Other Current Assets
2,570.00
1,168.00
2,219.00
7,546.00
8,457.00
20,727
Total Current Assets
188,360.00
324,618.00
218,989.00
547,897.00
373,477.00
526,106
Net Property, Plant & Equipment
579.00
553.00
2,203.00
3,081.00
2,662.00
3,309
Total Investments and Advances
-
-
375.00
2,375.00
2,475.00
4,826
Intangible Assets
-
-
-
7,015.00
5,538.00
4,062
Other Assets
179.00
287.00
329.00
785.00
354.00
1,899
Total Assets
189,118.00
325,458.00
221,896.00
561,153.00
384,506.00
540,202
Accounts Payable
372.00
2,016.00
1,672.00
3,912.00
8,786.00
Other Current Liabilities
6,607.00
13,818.00
20,230.00
38,673.00
40,244.00
Total Current Liabilities
6,979.00
15,834.00
21,902.00
42,585.00
49,030.00
Other Liabilities
8.00
135.00
232.00
157.00
191.00
Total Liabilities
6,987.00
15,969.00
22,134.00
42,742.00
49,221.00
Common Equity (Total)
182,131.00
309,489.00
199,762.00
518,411.00
335,285.00
Total Shareholders' Equity
182,131.00
309,489.00
199,762.00
518,411.00
335,285.00
Total Equity
182,131.00
309,489.00
199,762.00
518,411.00
335,285.00
Liabilities & Shareholders' Equity
189,118.00
325,458.00
221,896.00
561,153.00
384,506.00

About ACADIA Pharmaceuticals

View Profile
Address
3611 Valley Centre Drive
San Diego California 92130
United States
Employees -
Website http://www.acadia-pharm.com
Updated 07/08/2019
ACADIA Pharmaceuticals, Inc. operates as a biopharmaceutical company focused on the development and commercialization of medicines to address unmet medical needs in central nervous system, or CNS, disorders. It operates through development and commercialization of innovative medicines segment. The company was founded by Mark R.